Sep 30, 2019
Neovasc's Tiara(TM) for Treatment of Mitral Regurgitation and Neovasc Reducer(TM) for Treatment of Refractory Angina Featured in Multiple Presentations at TCT 2019 Conference
Sep 30, 2019
AltaValve(TM), 4C Medical's Novel Transcatheter Mitral Regurgitation Device Highlighted at TCT 2019
Sep 29, 2019
Late-Breaking Data Shows Abbott's MitraClip(TM) is Cost Effective, Increases Life Expectancy and Improves Quality of Life
Sep 28, 2019
New Data Demonstrate Strong Outcomes for Abbott Device to Repair Leaky Tricuspid Heart Valves
Sep 26, 2019
CorMatrix® Cardiovascular, Inc. completes enrollment of adult arm of its FDA early feasibility IDE study for the Cor® TRICUSPID ECM® valve for pediatric and adult patients
Sep 24, 2019
Minimally Invasive Delivery of the Mitral Touch and 1-Year Follow-Up of the ENRAPT-MR Study will be Presented at EACTS 2019 Techno College
Sep 23, 2019
Tiara(TM) for Treatment of Mitral Regurgitation and Neovasc Reducer(TM) for Treatment of Refractory Angina to be Featured at TCT 2019 Conference
Sep 12, 2019
REDUCE FMR Study Shows Cardiac Dimensions' Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure
Sep 04, 2019
Neovasc to Present at the H.C. Wainwright 21st Annual Global Investment Conference
Aug 16, 2019
FDA expands indication for several transcatheter heart valves to patients at low risk for death or major complications associated with open-heart surgery
Jul 15, 2019
Abbott Receives U.S. Approval of Next-Generation MitraClip®, Bringing New Enhancements to Abbott's Leading MitraClip Platform
Jun 27, 2019
Neovasc Announces Presentations on Tiara(TM) for Treatment of Mitral Regurgitation and Reducer(TM) for Treatment of Refractory Angina at the CSI Frankfurt 2019 Conference
Jun 21, 2019
Imminent Decision on Medicare Coverage of TAVR; New Research Shows Patients Benefit in Recovery
Jun 12, 2019
Transseptal Solutions Announces First Clinical Use of TSP Crosser(TM) in the United States
Jun 11, 2019
The cardiac restoration systems market will register a CAGR of over 5% by 2023
May 23, 2019
New Tiara and Reducer Data Presented in Several Presentations at the EuroPCR 2019 Conference in Paris
May 21, 2019
TRILUMINATE Study Shows Treatment with Abbott's First-of-its-Kind Minimally Invasive Device Reduces Tricuspid Heart Valve Leaks
May 02, 2019
Global Heart Valve Repair and Replacement Devices Market to 2023 - Key Vendors are Abbott, Boston Scientific, CryoLife, Edwards Lifesciences, LivaNova, & Medtronic
Apr 26, 2019
New Data Confirms Cardiac Dimensions' Carillon® System Provides Acute Hemodynamic Efficacy In Patients With Functional Mitral Regurgitation
Apr 23, 2019
Boston Scientific Receives FDA Approval for LOTUS Edge(TM) Aortic Valve System